At a glance
ClinicalIndex Comparison RecordN/ACompleted· 65 enrolled
Drug / intervention
PUFA Diet +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Role of Dietary Fatty Acids in Fatty Liver and Insulin Resistance: a Randomized Controlled Study
In Brief
A clinical study evaluating PUFA Diet and SFA diet for Obesity and 3 related conditions. Completed, enrolled 65 participants across 1 site.
Detailed Summary
The purpose of this study is to investigate whether substituting saturated fats with polyunsaturated fats reduces fatty liver and improves insulin action and other metabolic variables in abdominally obese subjects
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity, Diabetes, Insulin Resistance, Fatty Liver
CountriesSweden
CollaboratorsSwedish Council for Working Life and Social Research
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2009
First PostedDec 2009
Primary CompletionApr 2010
TodayJul 2026
First PostedDec 23, 2009
Enrollment StartFeb 1, 2009
Primary CompletionApr 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 16.5 years ago
Interventions
PUFA Dietother
Diet high in polyunsaturated (rich in linoleic acid, omega-6) fat (15 E%).
SFA dietother
Diet high in saturated fat (15E%)